Nicole Rogers

Clinical Team Lead

Nicole Rogers

Nicole Rogers

Clinical Team Lead

Nicole Rogers has more than 15 years of clinical research experience across therapeutically diverse Phase 1-4 studies, including 11 years dedicated to Cystic Fibrosis (CF) clinical research at the CFF Therapeutics Development Network Coordinating Center (TDNCC).  At TDNCC, Nicole focused on leading complex clinical trials from inception to successful study completion to pave the way for new CF treatments.

Nicole’s CF experience encompasses many therapeutic areas, including pulmonary, gastrointestinal, and infectious disease. She has experience with common CF outcome measures in both pediatric and adult patient populations including, spirometry, microbiology and inflammatory markers, patient reported outcomes, and sweat chloride.

Nicole’s clinical trial expertise includes the development of clinical trial protocols, informed consent forms, case report forms, clinical monitoring plans, as well as other various study manuals. Throughout her 15-year career, she has conducted all types of monitoring visits (on-site and remote) and developed collaborative working relationships with investigative sites. Nicole is passionate about mentoring and developing clinical research skills in all members of her study teams, which she views as a key to setting up clinical studies for success.

Why Cystic Fibrosis?

“It has been amazing to see the advances made in CF treatments in the past 10 years. However, there is still so much more to do for every CF patient to benefit and eventually get to a cure.  The CF community is truly special with the involvement from CF patients and families, researchers, health workers, and so many others. I feel honored to be able to collaborate with such a passionate and wonderful community.”

This is what drives Nicole:

“My strong sense of purpose at work helps drive me to be passionate, innovative and committed.  Working in clinical research gives me purpose and I strive to ensure clinical trials are successful so they can benefit the population they are serving.”